About
Diagnostics, CAR-T treatments
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalStem Cell & Cellular TherapyBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
45
By Phase
PHASE1: 1EARLY_PHASE1: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05316129Collaborator
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
PHASE1Recruiting
10 participants
Started: Apr 28, 2022 · Completed: May 31, 2029
NCT04674306Collaborator
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer
EARLY_PHASE1Active, not recruiting
35 participants
Started: Oct 1, 2021 · Completed: May 31, 2026
Locations (1)
Headquarters
San Jose, CA, United States
Map
Loading map...